The Effect Of Aspirin On Survival in in Patients Undergoing Chronic Hemodialysis

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02261025

Enrollment

410

Registered

2014-10-09

Start date

2008-01-31

Completion date

2014-09-30

Last updated

2014-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis

Keywords

aspirin

Brief summary

The aim of present study is to examine the effect of low-dose aspirin on the incidence of cardiovascular events and mortality in patients undergoing chronic hemodialysis.

Detailed description

This study prospectively evaluate the impacts of low dose aspirin on survival and cardio-cerebral vascular events in a large cohort of Chinese patients undergoing chronic hemodialysis. Between January 2008, consecutive patients with hemodialysis with aspirin were enrolled.We examine the association of aspirin with all-cause mortality in patients matched by propensity scores using the Kaplan-Meier method and Cox models in intention-to-treat analyses.The secondary endpoint was rate of cardio-cerebral events.

Interventions

DRUGacetylsalicylic acid

75-100mg,per day

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

All patients aged 18 to 85, undergoing chronic hemodialysis, who have none of the following

Exclusion criteria

Design outcomes

Primary

Measure	Time frame
survival rate	5 years

Secondary

Measure	Time frame
cardio-cerebral event	5 years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026